Last reviewed · How we verify
NCT05509829: LAUREN
EvaLuating negAtive pressUre Wound theRapy in brEast coNserving Surgery
NA trial testing Negative pressure wound therapy in Breast Cancer in 300 participants. Status unknown.
1 September 2023
Quick facts
| Lead sponsor | Zuyderland Medisch Centrum |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 300 |
| Start date | 1 May 2023 |
| Primary completion | 1 September 2023 |
| Estimated completion | 1 December 2023 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Negative pressure wound therapy
Conditions studied
- Breast Cancer — all drugs for Breast Cancer →
- Seroma — all drugs for Seroma →
- Wound Complication — all drugs for Wound Complication →
Sponsor
Zuyderland Medisch Centrum — full company profile →
Who can join
18 and older, female only, with Breast Cancer or Seroma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Negative pressure wound therapy (NPWT) could improve surgical outcomes and reduce complications like SSI, wound dehiscence and seroma in closed surgical wounds. To date, NPWT was not evaluated in patients undergoing breast conserving surgery without direct reconstruction.Therefore, the aim of this trial is to evaluate the feasibility of NPWT after surgery and its effects on postoperative complications.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05509829
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Negative pressure wound therapy
Trials testing the same drug.
- NCT03942575 — The Risk of Postoperative Wound Complications Following the Use of Negative Pressure Wound Therapy in Patients Undergoin · NA · completed
- NCT03566641 — Negative Pressure Wound Therapy vs Standard Care Dressing · NA · withdrawn
- NCT03433937 — Prevention of Seroma Following Inguinal Lymph Node Dissection With Prophylactic Incisional Negative Pressure Wound Thera · NA · terminated
- NCT02289157 — Negative Pressure Wound Therapy in Cesarean Section · NA · completed
- NCT01905397 — Negative Pressure Wound Therapy to Reduce Surgical Site Infection · NA · completed
Other recruiting trials for Breast Cancer
Currently open trials in the same condition.
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
- NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
- NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
- NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
- NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting
Other Zuyderland Medisch Centrum trials
Trials by the same sponsor.
- NCT06896812 — A Pilot Study on App-based Treatment Combining Physical Exercise, Graded Activity, and Pain Journaling for Patients with · NA · not yet recruiting
- NCT05941351 — fixAtion of skiN Flaps After Mastectomy Using ruNning or Interrupted suturEs for Combatting Seroma · NA · not yet recruiting
- NCT06219018 — Effect of Honey For CIN II · Phase 1, PHASE2 · recruiting
- NCT06827834 — Spinal Cord Monitoring in Multiple Sclerosis · recruiting
- NCT06381518 — Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel Disease · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05509829 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zuyderland Medisch Centrum
- Last refreshed: 7 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05509829.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing